Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2021 · 10-Q
Revenue$6.28M$6.28M+111.6% vs Q2 2020 Net Income-$1.21M-$1.21MN/M vs Q2 2020 EPS Diluted-$0.16-$0.16N/M vs Q2 2020 Gross Profit$5,740,728+119.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$334,291N/M Free Cash Flowderived-$355,346N/M Margins · derivedGross margin91.5%+3.2 pt vs Q2 2020
Operating margin-16.3%+20.0 pt vs Q2 2020
Net margin-19.2%+18.9 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end